Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Serbin Richard S, Director. Officer active across 2 companies, notably Co-Diagnostics, Inc.. Cumulatively, 10 reports have been recorded. History available since 8 January 2022. The latest transaction was disclosed on 23 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Richard S. Serbin is a Director of Co-Diagnostics, Inc. He plays a key role in overseeing the company's activities and strategic decision-making. His expertise in diagnostics contributes to guiding the company's initiatives towards innovation and efficiency.